Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
1(7%)
Results Posted
13%(1 trials)
Terminated
2(14%)

Phase Distribution

Ph not_applicable
9
64%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(8)
Terminated(2)
Other(3)

Detailed Status

Completed8
unknown3
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (10.0%)
N/A9 (90.0%)

Trials by Status

active_not_recruiting17%
completed857%
terminated214%
unknown321%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
OTHER
Total Trials
14